Pfizer reported mid‑stage results showing atirmociclib plus fulvestrant cut progression or death risk by about 40% in patients previously treated with CDK4/6 inhibitors.

A Washington State University study tested 719 academic hypotheses and found ChatGPT often returned incorrect or unstable answers, prompting calls for human verification.

Texas Tech researchers used ATR‑FTIR and Raman spectroscopy with machine learning to identify fentanyl exposure in fingernail clippings, a noninvasive method presented at Pittcon.

An investigation ties contaminated medicines, falsified testing and inspection gaps to overseas factories — and patients are already paying the price.

Federal probes into banks' AI hiring tools raise questions about bias in résumé screeners. Here’s what researchers and regulators are watching and how applicants can respond.

A coalition of tech researchers sued in D.C., arguing a visa policy singles out foreign experts who study social media and chills vital research.

A Senate committee backed a NASA reauthorization that would extend the ISS to Sept. 30, 2032 and direct NASA to develop a permanent Moon base. The move shifts timelines for the Space Coast and commercial station builders.

The LCME has listed Howard University College of Medicine as "Full, on probation." The university says accreditation and students’ degrees remain valid while it submits required fixes.

Trump Media said it is in talks to spin off Truth Social and merge the platform with a SPAC after its planned merger with fusion firm TAE Technologies.

Global agencies warn attackers are exploiting a critical Cisco SD‑WAN flaw; immediate patching and threat hunts are required.

Honest Health raised $140 million in a round led by NewSpring to grow its value‑based care partnerships. The Nashville company says the money will fund market expansion and system deals.

UC San Diego’s three‑hit model and international analyses link metabolic stress and parental chemical intolerance to autism risk, but experts urge caution. Larger trials are needed.

Livermore‑based Aalyria closed a $100M Series B at about a $1.3B valuation to scale its Spacetime orchestration software and Tightbeam laser terminals. Investors backed the spinout to speed commercial and government deployments.